mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |